Cargando…

Protocol for evaluation of neurotrophic strategies in Parkinson’s disease-related dopaminergic and sympathetic neurons in vitro

Parkinson’s disease (PD) is a neurodegenerative disease that is characterized by motor and non-motor symptoms which result from the progressive degeneration of nigrostriatal ventral midbrain (VM) dopaminergic (DA) neurons, as well as peripheral sympathetic neurons. PD is incurable, with current ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hegarty, Shane V., Sullivan, Aideen M., O’Keeffe, Gerard W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	jbm 2016
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706149/ https://www.ncbi.nlm.nih.gov/pubmed/31453215 http://dx.doi.org/10.14440/jbm.2016.124

Ejemplares similares

Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease
por: O'Keeffe, Gerard W., et al.
Publicado: (2017)

Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2014)

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2017)

Neurotrophic factor therapy for Parkinson's disease: past, present and future
por: Sullivan, Aideen M., et al.
Publicado: (2016)

Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson’s disease
por: Hegarty, Shane V., et al.
Publicado: (2018)

The Epigenome as a therapeutic target for Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2016)

The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease
por: Goulding, Susan R., et al.
Publicado: (2020)

Zeb2 is a negative regulator of midbrain dopaminergic axon growth and target innervation
por: Hegarty, Shane V., et al.
Publicado: (2017)

Editorial: The Role of Stem Cells, Epigenetics and MicroRNAs in Parkinson's Disease
por: Hegarty, Shane V., et al.
Publicado: (2020)

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease
por: Goulding, Susan R., et al.
Publicado: (2021)

Diet quality, sleep and quality of life in Parkinson’s disease: a cross-sectional study
por: Dunk, Danielle, et al.
Publicado: (2022)

The dietary flavonoid isoliquiritigenin is a potent cytotoxin for human neuroblastoma cells
por: Alshangiti, Amnah M., et al.
Publicado: (2019)

The class II histone deacetylases as therapeutic targets for Parkinson’s disease
por: Mazzocchi, Martina, et al.
Publicado: (2020)

Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease
por: Costello, Daniel J, et al.
Publicado: (2012)

4-Hydroxychalcone Induces Cell Death via Oxidative Stress in MYCN-Amplified Human Neuroblastoma Cells
por: Alshangiti, Amnah M., et al.
Publicado: (2019)

STRAP and NME1 Mediate the Neurite Growth-Promoting Effects of the Neurotrophic Factor GDF5
por: Anantha, Jayanth, et al.
Publicado: (2020)

A detailed protocol for RNA cleavage assay in sympathetic neurons
por: Andreassi, Catia, et al.
Publicado: (2021)

Assessment of dopaminergic neuron degeneration in a C. elegans model of Parkinson’s disease
por: Palikaras, Konstantinos, et al.
Publicado: (2022)

Association of distinct type 1 bone morphogenetic protein receptors with different molecular pathways and survival outcomes in neuroblastoma
por: Alshangiti, Amnah M., et al.
Publicado: (2020)

Optogenetic induction of alpha-synuclein aggregation in human dopaminergic neurons to model Parkinson’s disease pathology
por: Ra, Eun A., et al.
Publicado: (2023)

A protocol for the differentiation of human embryonic stem cells into midbrain dopaminergic neurons
por: Nishimura, Kaneyasu, et al.
Publicado: (2023)

Protocol for measurement of calcium dysregulation in human induced pluripotent stem cell-derived dopaminergic neurons
por: Yin, Xiling, et al.
Publicado: (2021)

Optimized protocol for the generation of functional human induced-pluripotent-stem-cell-derived dopaminergic neurons
por: Sheta, Razan, et al.
Publicado: (2023)

Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson’s disease: a systematic review protocol
por: Karimi, Aliasghar, et al.
Publicado: (2021)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Expression of endogenous Mkp1 in 6-OHDA rat models of Parkinson’s disease
por: Collins, Louise M, et al.
Publicado: (2014)

Ciliary neurotrophic factor induces cholinergic differentiation of rat sympathetic neurons in culture
Publicado: (1989)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Mammalian target of rapamycin complex 1 as an inducer of neurotrophic factors in dopaminergic neurons
por: Kim, Sang Ryong
Publicado: (2014)

Preparation and Co‐Culture of iPSC‐Derived Dopaminergic Neurons and Astrocytes
por: de Rus Jacquet, Aurelie
Publicado: (2019)

Characterizing neurotrophic factor-induced synaptic growth in primary mouse neuronal cultures
por: He, Guiqin, et al.
Publicado: (2022)

Neuroprotective Effect and Mechanism of Thiazolidinedione on Dopaminergic Neurons In Vivo and In Vitro in Parkinson's Disease
por: Wang, Yanqin, et al.
Publicado: (2017)

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
por: Bengoa-Vergniory, Nora, et al.
Publicado: (2020)

Cistanche tubulosa Protects Dopaminergic Neurons through Regulation of Apoptosis and Glial Cell-Derived Neurotrophic Factor: in vivo and in vitro
por: Xu, Qian, et al.
Publicado: (2016)

Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling
por: Mazzocchi, Martina, et al.
Publicado: (2019)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Axon Guidance of Sympathetic Neurons to Cardiomyocytes by Glial Cell Line-Derived Neurotrophic Factor (GDNF)
por: Miwa, Keiko, et al.
Publicado: (2013)

NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease
por: Anantha, Jayanth, et al.
Publicado: (2021)

Region-specific role of growth differentiation factor-5 in the establishment of sympathetic innervation
por: O’Keeffe, Gerard W., et al.
Publicado: (2016)

Diverse midbrain dopaminergic neuron subtypes and implications for complex clinical symptoms of Parkinson’s disease
por: Carmichael, Kathleen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_80ptkne6599abkg1aesbi8vviq